The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mechanisms of acquired resistance to MET tyrosine kinase inhibitors (TKIs) in MET exon 14 (METex14) mutant non-small cell lung cancer (NSCLC).
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Merck; Nektar; Novartis; Pfizer; Syndax
Research Funding - Bristol-Myers Squibb
 
Magda Bahcall
Patents, Royalties, Other Intellectual Property - Loxo
 
Lynette M. Sholl
Consulting or Advisory Role - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
Other Relationship - Gfk; Research to Practice
 
Frederick Hugh Wilson
No Relationships to Disclose
 
Cloud Paweletz
Consulting or Advisory Role - Bio-Rad; Digital Bioanaytics
 
Marzia Capelletti
No Relationships to Disclose
 
Giulia Costanza Leonardi
No Relationships to Disclose
 
Masayuki Watanabe
No Relationships to Disclose
 
Hideo Baba
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Covidien (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Toyama Chemical Co (Inst); Yakult Honsha (Inst)
 
Emily S. Chambers
No Relationships to Disclose
 
Amanda J. Redig
Employment - Takeda
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Medtronic; Roche
 
Mizuki Nishino
Honoraria - Bayer Yakuhin; Roche Pharma AG
Consulting or Advisory Role - Daiichi Sankyo; Toshiba; WorldCare Clinical, LLC
Research Funding - AstraZeneca (Inst); Merck (Inst); Toshiba (Inst)
 
Paul A VanderLaan
Consulting or Advisory Role - Gala Therapeutics
 
Daniel Botelho Costa
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca
 
Yu Imamura
No Relationships to Disclose
 
Pasi A. Janne
Stock and Other Ownership Interests - Gatekeeper Pharmaceuticals
Consulting or Advisory Role - Araxes Pharma; ARIAD; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Ignyta; Lilly; LOXO; Merrimack; Mirati Therapeutics; Pfizer; Roche/Genentech
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Puma Biotechnology
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a DFCI owned patent on EGFR mutations licensed to Lab Corp. I receive post-marketing royalties from this invention